Brain aneurysm is a bulging or balloon-like growth in humans, which appears typically in the areas where large arteries branch into smaller ones, generally observed at the base of the brain. Brain aneurysm is also known as cerebral aneurysm or intracranial aneurysm. Aneurysm has the potential to rupture, which causes bleeding in the surrounding sub-arachnoid space, generally resulting in brain damage or stroke. Sometimes, it may lead to even death. Brain aneurysm rarely has any symptoms until the swelling ruptures. However, double vision, localized headache, and cranial nerve palsy are a few symptoms of mass effect of brain aneurysm on adjacent neurological structures. Key causes of brain aneurysm include heredity, aging, atherosclerosis infection, and brain injury.
Ruptured brain aneurysm is a critical condition and in a few cases, it could be fatal. It is generally diagnosed with the help of magnetic resonance angiography, cerebral angiography, or computed tomography (CT) scan. Brain aneurysm is one of the leading causes of hemorrhagic stroke. According to UCSF Medical Center, approximately 3%–5% of people in the U.S. are affected by brain aneurysm every year. It is mostly prevalent in adults aged 35–60 years. It is also observed to be more prevalent in women than men, with a prevalence ratio of 3:2. According to the Brain Aneurysm Foundation, 1 in 50 people in the U.S. have brain aneurysm. Of these, 40% of the cases are fatal and 60% of the cases suffer from a permanent neurological defect. Every year, 500,000 people die of brain aneurysm across the world. Of these, 50% people are aged 50 years or below. According to a research study conducted by Karger Journal, the rate of mortality after the conservative treatment in the first few months is 50%–60%.
The Federal government spends a mere US$ 0.83 per afflicted person per year on brain aneurysm research. Significant developments over the last few years with volumes of supporting data, rise in the adoption of advanced technologies for the diagnosis and treatment of brain aneurysm, and the genetic factor responsible for occurrence of the disease are factors fueling the brain aneurysm treatment market. On the other hand, high cost of the treatment and unrecognized symptoms of the brain aneurysm are considered to be major restraining factors for the market.
Based on treatment type, the brain aneurysm treatment market has been segmented into medication and surgery. The surgery segment has been sub-segmented into endovascular coiling, flow diverters, surgical clipping, and others. The flow diverters sub-segment has been further divided into silk flow diverters, pipeline embolization devices, and surpass flow diverters. The medication segment has been sub-segmented into analgesics, antiemetics, anti-seizure medications, calcium channel blockers, antacids, and others.
Based on type, the brain aneurysm treatment market has been segmented into unruptured aneurysm and ruptured aneurysm. The ruptured aneurysm segment holds a major market share, due to prominent symptoms of ruptured aneurysm and ease of diagnosis. However, advancing technologies in diagnostics and growing initiatives for regular health screenings are anticipated to propel the unruptured aneurysm segment during the forecast period. Based on end-user, the market has been segmented into hospitals, specialty clinics, and others.
Based on geography, the brain aneurysm treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the global market during the forecast period, due to availability of advanced screening processes, high health care expenditure, and rise in awareness about the disease in the region. Asia Pacific is expected to be a rapidly growing market for brain aneurysm treatment from 2017 to 2025, due to the rising number of patients, improved diagnosis, and developing health care infrastructure in the region.
Some of the key players operating in the brain aneurysm treatment market are Raumedic AG, DePuy Synthes, Integra Life Sciences Corporation, Orsan Medical Technologies, Spiegelberg GmbH, MicroPort Scientific Corporation, Medtronic Plc., and Codman & Shurtleff, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.